Semaglutide studies: 1,194 papers with results
Page 10 of 24
- Obesity medications in patients with recurrent weight gain or suboptimal clinical response following bariatric surgery: a meta-analysis.
Golzarand M · International journal of obesity (2005) · 2025
Systematic review · 2 results
- Cardiovascular Safety Profile of Semaglutide and Variations by Sex, Race, and Kidney Function: A Systematic Review and Meta-analysis.
Hamayal M · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
Systematic review · 5 results
- Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis.
Bhaduri G · Clinical obesity · 2026
Systematic review · 3 results
- GLP-1 Receptor Agonists in Heart Failure: A Systematic Review and Meta-analysis with Phenotype-Specific Effects and Dual Analytical Frameworks.
Yuan Y · Drugs · 2026
Systematic review · 16 results
- Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials.
Shao C · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Systematic review · 33 results
- GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.
Beaudart C · Drugs · 2026
Systematic review · 20 results
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.
Qi H · PeerJ · 2026
Systematic review · 17 results
- Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review.
Puspitasari IM · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Systematic review · 10 results
- Body Composition and Lifestyle Interventions in Pharmacological Treatment of Acquired Hypothalamic Obesity: A Systematic Review of Randomized Controlled Trials.
Yu H · Obesity (Silver Spring, Md.) · 2026
Systematic review · 2 results
- Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.
Moiz A · Annals of internal medicine · 2026
Systematic review · 28 results
- Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.
Santos-Pereira M · Frontiers in endocrinology · 2026
Systematic review · 10 results
- Maximizing weight loss with cagrisema: a systematic review and GRADE-assessed meta-analysis of randomized controlled trials.
Khan BW · Naunyn-Schmiedeberg's archives of pharmacology · 2026
Systematic review · 14 results
- Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis.
Chen QX · Endocrine · 2026
Systematic review · 5 results
- Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes.
Olubodun T · PloS one · 2026
Systematic review · 28 results
- From pathobiology to prescribing in obesity-driven HFpEF: A systematic review and practical therapeutic framework.
Alhazmi AM · Current problems in cardiology · 2026
Systematic review · 6 results
- Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
Pałka W · Journal of endocrinological investigation · 2026
Systematic review · 22 results
- Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis.
Alnaimi SJ · Clinical obesity · 2026
Systematic review · 1 result
- Nutritional intake changes during GLP-1 receptor agonist therapy: A systematic review and meta-analysis.
Quan AT · Diabetes & metabolic syndrome · 2026
Systematic review · 6 results
- GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.
Sajjad M · Multiple sclerosis and related disorders · 2026
Systematic review · 2 results
- GLP-1 receptor agonist therapy in children and adolescents with obesity: A network meta-analysis of differential cardiometabolic efficacy and safety profiles.
Li Y · Pharmacological research · 2026
Systematic review · 4 results
- Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment.
Khan S · Medicine · 2026
Systematic review · 8 results
- Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis.
Yang Q · BMC ophthalmology · 2026
Systematic review · 8 results
- GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety.
Soliman AT · Diabetes research and clinical practice · 2026
Systematic review · 18 results
- Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Mahoon D · International journal of molecular sciences · 2026
Systematic review · 16 results
- Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs).
Laverde LP · International journal of obesity (2005) · 2026
Systematic review · 4 results
- Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials.
Wu X · Frontiers in pharmacology · 2026
Systematic review · 24 results
- SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review.
Cruz AM · European journal of clinical pharmacology · 2026
Systematic review · 3 results
- Differential impact of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss in the type 2 diabetic and non-diabetic populations.
Jia IT · Surgical endoscopy · 2026
Systematic review · 16 results
- Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measurement of Body Composition Among Adults With Overweight or Obesity With or Without Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.
Wachiraphansakul N · Diabetes, obesity & metabolism · 2026
Systematic review · 24 results
- Semaglutide and risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) in type 2 diabetes mellitus: A systematic review and meta-analysis.
Lampsas S · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
Systematic review · 4 results
- GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review.
Myśliwczyk D · Nutrients · 2026
Systematic review · 10 results
- Effect of oral semaglutide on cardiometabolic risk factors in overweight and obese individuals with or without diabetes: a systematic review and meta-analysis.
Seighali N · BMC pharmacology & toxicology · 2026
Systematic review · 11 results
- Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.
Chrzanowski J · PLoS medicine · 2026
Systematic review · 4 results
- Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hung TH · Human psychopharmacology · 2026
Systematic review · 15 results
- Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.
Ciudin A · Diabetes, obesity & metabolism · 2026
Systematic review · 10 results
- Effect of Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) on Neuropsychiatric Outcomes: A Systematic Review and Meta-Analysis.
Choudhury I · Clinical therapeutics · 2026
Systematic review · 29 results
- Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
Au HCT · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Systematic review · 5 results
- Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity.
Raveendra K · ESC heart failure · 2026
Systematic review · 4 results
- Efficacy and safety of anti-prediabetic drugs in patients with prediabetes: a Bayesian network meta-analysis.
Wu Y · BMC medicine · 2026
Systematic review · 4 results
- Association Between GLP-1 Receptor Agonists and the Risk of Colon Cancer in Adults With Type 2 Diabetes or Obesity: A Systematic Review and Network Meta-Analysis.
Guo M · Diabetes/metabolism research and reviews · 2026
Systematic review · 5 results
- Recurrent Weight Gain after Weight Loss Induced by Lifestyle Intervention, Metabolic and Bariatric Surgery, or Semaglutide in Adults with Obesity: A Systematic Review of Randomized Controlled Trials.
Chen H · Obesity surgery · 2026
Systematic review · 2 results
- GLP-1 receptor agonists and alcohol use disorder: a systematic review.
Patel S · Alcohol and alcoholism (Oxford, Oxfordshire) · 2025
Systematic review · 1 result
- Effect of semaglutide with obesity or overweight individuals without diabetes: an Umbrella review of systematic reviews.
Hu X · Endocrine · 2025
Systematic review · 16 results
- Time-Efficacy Relationship of Semaglutide in the Treatment of Type 2 Diabetes Mellitus: A Model-Based Meta-Analysis.
Zhang K · Clinical pharmacokinetics · 2024
Systematic review · 8 results
- Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study.
Huang YS · Obesity surgery · 2026
Non-randomized trial · 9 results
- Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).
Strojek K · Diabetes, obesity & metabolism · 2026
Non-randomized trial · 6 results
- Comparative effectiveness of sleeve gastrectomy and semaglutide for weight loss and metabolic outcomes: a prospective non-randomized study.
Yen Y · BMC medicine · 2026
Non-randomized trial · 6 results
- Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment.
Baekdal TA · Journal of clinical pharmacology · 2018
Non-randomized trial · 5 results
- Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes.
Meier JJ · Diabetes, obesity & metabolism · 2022
Non-randomized trial · 6 results
- Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment.
Jensen L · Diabetes, obesity & metabolism · 2018
Non-randomized trial · 3 results